BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mandard AM, Hainaut P, Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res. 2000;462:335-342. [PMID: 10767643 DOI: 10.1016/s1383-5742(00)00019-3] [Cited by in Crossref: 139] [Cited by in F6Publishing: 70] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Fong LY, Taccioli C, Jing R, Smalley KJ, Alder H, Jiang Y, Fadda P, Farber JL, Croce CM. MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency. Oncotarget 2016;7:10723-38. [PMID: 26918602 DOI: 10.18632/oncotarget.7561] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
2 Yang Y, Nakagawa H, Tetreault MP, Billig J, Victor N, Goyal A, Sepulveda AR, Katz JP. Loss of transcription factor KLF5 in the context of p53 ablation drives invasive progression of human squamous cell cancer. Cancer Res. 2011;71:6475-6484. [PMID: 21868761 DOI: 10.1158/0008-5472.CAN-11-1702] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
3 Zhao C, Gong L, Li W, Chen L. Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2010;136:9-16. [PMID: 19572149 DOI: 10.1007/s00432-009-0630-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
4 Okawa T, Michaylira CZ, Kalabis J, Stairs DB, Nakagawa H, Andl CD, Johnstone CN, Klein-Szanto AJ, El-Deiry WS, Cukierman E. The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Genes Dev. 2007;21:2788-2803. [PMID: 17974918 DOI: 10.1101/gad.1544507] [Cited by in Crossref: 126] [Cited by in F6Publishing: 123] [Article Influence: 9.0] [Reference Citation Analysis]
5 Islamian JP, Mohammadi M, Baradaran B. Inhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overview. Cancer Biol Med 2014;11:78-85. [PMID: 25009749 DOI: 10.7497/j.issn.2095-3941.2014.02.002] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Wang Z, Tang L, Sun G, Tang Y, Xie Y, Wang S, Hu X, Gao W, Cox SB, Wang JS. Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China. BMC Cancer. 2006;6:287. [PMID: 17173682 DOI: 10.1186/1471-2407-6-287] [Cited by in Crossref: 79] [Cited by in F6Publishing: 76] [Article Influence: 4.9] [Reference Citation Analysis]
7 Kong JP, Ding F, Zhou CN, Wang XQ, Miao XP, Wu M, Liu ZH. Loss of myeloid-related proteins 8 and myeloid-related proteins 14 expression in human esophageal squamous cell carcinoma correlates with poor differentiation. World J Gastroenterol 2004; 10(8): 1093-1097 [PMID: 15069705 DOI: 10.3748/wjg.v10.i8.1093] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
8 Toh Y, Oki E, Ohgaki K, Sakamoto Y, Ito S, Egashira A, Saeki H, Kakeji Y, Morita M, Sakaguchi Y. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol. 2010;15:135-144. [PMID: 20224883 DOI: 10.1007/s10147-010-0057-6] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 7.6] [Reference Citation Analysis]
9 Lehman HL, Yang X, Welsh PA, Stairs DB. p120-catenin down-regulation and epidermal growth factor receptor overexpression results in a transformed epithelium that mimics esophageal squamous cell carcinoma. Am J Pathol 2015;185:240-51. [PMID: 25529795 DOI: 10.1016/j.ajpath.2014.09.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
10 Nicolau-Neto P, Palumbo A, De Martino M, Esposito F, de Almeida Simão T, Fusco A, Nasciutti LE, Meireles Da Costa N, Ribeiro Pinto LF. UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1. Genes (Basel) 2018;9:E188. [PMID: 29596365 DOI: 10.3390/genes9040188] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
11 Luo A, Yu X, Li G, Ma G, Chen H, Ding F, Li Y, Liu Z. Differentiation-associated genes regulated by c-Jun and decreased in the progression of esophageal squamous cell carcinoma. PLoS One 2014;9:e96610. [PMID: 24796531 DOI: 10.1371/journal.pone.0096610] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
12 Palumbo A Jr, Da Costa NM, De Martino M, Sepe R, Pellecchia S, de Sousa VP, Nicolau Neto P, Kruel CD, Bergman A, Nasciutti LE, Fusco A, Pinto LF. UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines. Oncotarget 2016;7:65876-87. [PMID: 27588470 DOI: 10.18632/oncotarget.11674] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
13 Opitz OG, Harada H, Suliman Y, Rhoades B, Sharpless NE, Kent R, Kopelovich L, Nakagawa H, Rustgi AK. A mouse model of human oral-esophageal cancer. J Clin Invest 2002;110:761-9. [PMID: 12235107 DOI: 10.1172/JCI15324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 41] [Article Influence: 0.1] [Reference Citation Analysis]
14 Maaser K, Däubler P, Barthel B, Heine B, von Lampe B, Stein H, Hoffmeister B, Scherer H, Scherübl H. Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis. Br J Cancer 2003;88:1217-22. [PMID: 12698187 DOI: 10.1038/sj.bjc.6600865] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
15 da Costa NM, Soares Lima SC, de Almeida Simão T, Ribeiro Pinto LF. The potential of molecular markers to improve interventions through the natural history of oesophageal squamous cell carcinoma. Biosci Rep 2013;33:e00057. [PMID: 23837802 DOI: 10.1042/BSR20130063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
16 Zhao CL, Chen LM, Gao ZQ, Du CQ, Pan ZF, Yu WJ. Clinical significance of cyclin B1 and cyclin-dependent kinase 1 expression in human esophageal squamous cell carcinoma. Shijie Huaren Xiaohua Zazhi 2009; 17(23): 2374-2378 [DOI: 10.11569/wcjd.v17.i23.2374] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Chen H, Wang LD, Guo M, Gao SG, Guo HQ, Fan ZM, Li JL. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China. World J Gastroenterol 2003; 9(1): 16-21 [PMID: 12508343 DOI: 10.3748/wjg.v9.i1.16] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
18 Taccioli C, Chen H, Jiang Y, Liu XP, Huang K, Smalley KJ, Farber JL, Croce CM, Fong LY. Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature. Oncogene 2012;31:4550-8. [PMID: 22179833 DOI: 10.1038/onc.2011.592] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]
19 Yazbeck R, Jaenisch SE, Watson DI. From blood to breath: New horizons for esophageal cancer biomarkers. World J Gastroenterol 2016; 22(46): 10077-10083 [PMID: 28028355 DOI: 10.3748/wjg.v22.i46.10077] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
20 Yao W, Jia X, Xu L, Li S, Wei L. MicroRNA-2053 involves in the progression of esophageal cancer by targeting KIF3C. Cell Cycle 2021;20:1163-72. [PMID: 34057012 DOI: 10.1080/15384101.2021.1929675] [Reference Citation Analysis]
21 Gholipour M, Islami F, Roshandel G, Khoshnia M, Badakhshan A, Moradi A, Malekzadeh R. Esophageal Cancer in Golestan Province, Iran: A Review of Genetic Susceptibility and Environmental Risk Factors. Middle East J Dig Dis 2016;8:249-66. [PMID: 27957288 DOI: 10.15171/mejdd.2016.34] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
22 Stoner GD, Wang LS, Chen T. Chemoprevention of esophageal squamous cell carcinoma. Toxicol Appl Pharmacol. 2007;224:337-349. [PMID: 17475300 DOI: 10.1016/j.taap.2007.01.030] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
23 Oyama K, Okawa T, Nakagawa H, Takaoka M, Andl CD, Kim SH, Klein-Szanto A, Diehl JA, Herlyn M, El-Deiry W, Rustgi AK. AKT induces senescence in primary esophageal epithelial cells but is permissive for differentiation as revealed in organotypic culture. Oncogene 2007;26:2353-64. [PMID: 17043653 DOI: 10.1038/sj.onc.1210025] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
24 He S, Guo GM, Liu FX, Huang XP, Xu X, Cai Y, Han YL, Zhan QM, Wu M, Dong JT, Wang GQ, Wang MR. Molecular analysis in combination with iodine staining may contribute to the risk prediction of esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2008;134:307-15. [PMID: 17701052 DOI: 10.1007/s00432-007-0269-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
25 Kim MS, Chang X, LeBron C, Nagpal JK, Lee J, Huang Y, Yamashita K, Trink B, Ratovitski EA, Sidransky D. Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma. PLoS One 2010;5:e9003. [PMID: 20140245 DOI: 10.1371/journal.pone.0009003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
26 Hosch SB, Stoecklein NH, Izbicki JR. Molecular markers and staging of early esophageal cancer. Langenbecks Arch Surg 2003;388:77-82. [PMID: 12712339 DOI: 10.1007/s00423-003-0353-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
27 Huang C, Chen W, Wang X, Zhao J, Li Q, Fu Z. Cripto-1 Promotes the Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma Cells. Evid Based Complement Alternat Med 2015;2015:421285. [PMID: 26472984 DOI: 10.1155/2015/421285] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
28 Tanière P, Martel-Planche G, Saurin JC, Lombard-Bohas C, Berger F, Scoazec JY, Hainaut P. TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe. Br J Cancer. 2001;85:721-726. [PMID: 11531258 DOI: 10.1054/bjoc.2001.1990] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
29 Grupp K, Hofmann B, Kutup A, Bachmann K, Bogoevski D, Melling N, Uzunoglu FG, El Gammal AT, Koop C, Simon R, Steurer S, Krech T, Burdak-Rothkamm S, Jacobsen F, Sauter G, Izbicki J, Wilczak W. Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome. BMC Cancer 2018;18:1106. [PMID: 30419865 DOI: 10.1186/s12885-018-5032-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lv XB, Lian GY, Wang HR, Song E, Yao H, Wang MH. Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PLoS One. 2013;8:e63516. [PMID: 23717443 DOI: 10.1371/journal.pone.0063516] [Cited by in Crossref: 115] [Cited by in F6Publishing: 121] [Article Influence: 12.8] [Reference Citation Analysis]
31 Koppert LB, Schutte M, Abbou M, Tilanus HW, Dinjens WN. The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis. Br J Cancer 2004;90:888-91. [PMID: 14970869 DOI: 10.1038/sj.bjc.6601551] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
32 Liu HJ, Zang ZZ, Hou QY, Lu JY, Yang J, Lin Z, Zhao YZ. Clinical significance of Syk expression in human esophageal squamous cell carcinoma. Shijie Huaren Xiaohua Zazhi 2010; 18(1): 33-38 [DOI: 10.11569/wcjd.v18.i1.33] [Reference Citation Analysis]
33 Liu WL, Guo XZ, Zhang LJ, Wang JY, Zhang G, Guan S, Chen YM, Kong QL, Xu LH, Li MZ, Song LB, Zeng MS. Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma. BMC Cancer. 2010;10:467. [PMID: 20809956 DOI: 10.1186/1471-2407-10-467] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
34 Wen D, Zhang L, Wang X, Wen X, Yang Y, Chen Y, Wang G, Akazawa K, Wang S, Shan B. Heterogeneity in esophageal and gastric cardia precursor progression during six-year endoscopic surveillance after population-based screening in a Chinese high-risk region. Thorac Cancer 2017;8:328-36. [PMID: 28440945 DOI: 10.1111/1759-7714.12446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 Opitz OG, Harada H, Suliman Y, Rhoades B, Sharpless NE, Kent R, Kopelovich L, Nakagawa H, Rustgi AK. A mouse model of human oral-esophageal cancer. J Clin Invest. 2002;110:761-769. [PMID: 12235107 DOI: 10.1172/jci0215324] [Cited by in Crossref: 62] [Cited by in F6Publishing: 1] [Article Influence: 3.1] [Reference Citation Analysis]
36 Huang YT, Yin XK, Zhong XY, Zhang H. Advances in rodent models of human esophageal squamous cell carcinoma. Shijie Huaren Xiaohua Zazhi 2011; 19(16): 1704-1710 [DOI: 10.11569/wcjd.v19.i16.1704] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Yang Y, Katz JP. KLF4 is downregulated but not mutated during human esophageal squamous cell carcinogenesis and has tumor stage-specific functions. Cancer Biol Ther 2016;17:422-9. [PMID: 26934576 DOI: 10.1080/15384047.2016.1156260] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
38 Sasaki Y, Tamura M, Koyama R, Nakagaki T, Adachi Y, Tokino T. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing. World J Gastroenterol 2016; 22(7): 2284-2293 [PMID: 26900290 DOI: 10.3748/wjg.v22.i7.2284] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
39 Taccioli C, Garofalo M, Chen H, Jiang Y, Tagliazucchi GM, Di Leva G, Alder H, Fadda P, Middleton J, Smalley KJ, Selmi T, Naidu S, Farber JL, Croce CM, Fong LY. Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo. J Natl Cancer Inst 2015;107:djv220. [PMID: 26286729 DOI: 10.1093/jnci/djv220] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
40 Kazemi-Noureini S, Colonna-Romano S, Ziaee AA, Malboobi MA, Yazdanbod M, Setayeshgar P, Maresca B. Differential gene expression between squamous cell carcinoma of esophageus and its normal epithelium; altered pattern of mal, akr1c2, and rab11a expression. World J Gastroenterol 2004; 10(12): 1716-1721 [PMID: 15188492 DOI: 10.3748/wjg.v10.i12.1716] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
41 Pirayesh Islamian J, Mohammadi M, Baradaran B, Farajollahi A, Aghamiri SM, Asghari Jafarabadi M, Karami H, Monfaredan A, Shanehbandi D. Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro. Bioimpacts 2016;6:93-8. [PMID: 27525226 DOI: 10.15171/bi.2016.13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
42 Zhang G, Zhang Q, Zhang Q, Yin L, Li S, Cheng K, Zhang Y, Xu H, Wu W. Expression of nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues. J Cancer Res Clin Oncol 2010;136:587-94. [PMID: 19823871 DOI: 10.1007/s00432-009-0693-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
43 Compagnin C, Mognato M, Celotti L, Canti G, Palumbo G, Reddi E. Cell proliferation and cell cycle alterations in oesophageal p53-mutated cancer cells treated with cisplatin in combination with photodynamic therapy. Cell Prolif 2010;43:262-74. [PMID: 20546244 DOI: 10.1111/j.1365-2184.2010.00673.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
44 Lin G, Sun XJ, Han QB, Wang Z, Xu YP, Gu JL, Wu W, Zhang GU, Hu JL, Sun WY, Mao WM. Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma. Oncol Lett 2015;10:901-6. [PMID: 26622592 DOI: 10.3892/ol.2015.3277] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
45 Yuan JM. Green tea and prevention of esophageal and lung cancers. Mol Nutr Food Res 2011;55:886-904. [PMID: 21538848 DOI: 10.1002/mnfr.201000637] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
46 Zhong C, Fan L, Li Z, Yao F, Zhao H. SREBP2 is upregulated in esophageal squamous cell carcinoma and co‑operates with c‑Myc to regulate HMGCR expression. Mol Med Rep 2019;20:3003-10. [PMID: 31432128 DOI: 10.3892/mmr.2019.10577] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
47 Reen RK, Dombkowski AA, Kresty LA, Cukovic D, Mele JM, Salagrama S, Nines R, Stoner GD. Effects of phenylethyl isothiocyanate on early molecular events in N-nitrosomethylbenzylamine-induced cytotoxicity in rat esophagus. Cancer Res 2007;67:6484-92. [PMID: 17616710 DOI: 10.1158/0008-5472.CAN-06-4531] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
48 Akizue N, Okimoto K, Arai M, Hirotsu Y, Amemiya K, Oura H, Kaneko T, Tokunaga M, Ishikawa K, Ohta Y, Taida T, Saito K, Maruoka D, Matsumura T, Nakagawa T, Nishimura M, Chiba T, Matsushita K, Mochizuki H, Yokosuka O, Omata M, Kato N. Comprehensive mutational analysis of background mucosa in patients with Lugol-voiding lesions. Cancer Med 2021;10:3545-55. [PMID: 33934524 DOI: 10.1002/cam4.3905] [Reference Citation Analysis]
49 Wang JH, Chen XT, Wen ZS, Zheng M, Deng JM, Wang MZ, Lin HX, Chen K, Li J, Yun JP. High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis. PLoS One. 2012;7:e45622. [PMID: 23056210 DOI: 10.1371/journal.pone.0045622] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
50 Lang B, Zhao S. miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2. Oncol Rep 2018;39:71-80. [PMID: 29115564 DOI: 10.3892/or.2017.6064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
51 Lv XB, Lian GY, Wang HR, Song E, Yao H, Wang MH. Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PLoS One. 2013;8:e63516. [PMID: 23717443 DOI: 10.1371/journal.pone.] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
52 Morgan S, Grandis JR. ErbB receptors in the biology and pathology of the aerodigestive tract. Exp Cell Res 2009;315:572-82. [PMID: 18778701 DOI: 10.1016/j.yexcr.2008.08.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
53 Taghavi N, Biramijamal F, Sotoudeh M, Moaven O, Khademi H, Abbaszadegan MR, Malekzadeh R. Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients. World J Gastroenterol 2010; 16(39): 4958-4967 [PMID: 20954283 DOI: 10.3748/wjg.v16.i39.4958] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
54 Fong LY, Taccioli C, Palamarchuk A, Tagliazucchi GM, Jing R, Smalley KJ, Fan S, Altemus J, Fiehn O, Huebner K, Farber JL, Croce CM. Abrogation of esophageal carcinoma development in miR-31 knockout rats. Proc Natl Acad Sci U S A. 2020;117:6075-6085. [PMID: 32123074 DOI: 10.1073/pnas.1920333117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
55 Cheng TH, Hsu PK, Li AF, Hung IC, Huang MH, Hsu HS. Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2009;135:1577-1582. [PMID: 19488782 DOI: 10.1007/s00432-009-0605-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
56 Yan W, Wistuba II, Emmert-Buck MR, Erickson HS. Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites. Am J Cancer Res 2011;1:275-300. [PMID: 21938273 DOI: 10.1158/1538-7445.am2011-275] [Cited by in Crossref: 10] [Cited by in F6Publishing: 54] [Article Influence: 1.3] [Reference Citation Analysis]
57 Han Y, Guo XH, Zheng QF, Zhu YL, Fan YY, Zhang XY. Down-regulation of platelet-derived growth factor-D expression blockades NF-κB pathway to inhibit cell proliferation and invasion as well as induce apoptosis in esophageal squamous cell carcinoma. Mol Biol Rep. 2013;40:2473-2483. [PMID: 23187740 DOI: 10.1007/s11033-012-2328-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
58 Yang S, Feng T, Li H. KLF5, a Novel Therapeutic Target in Squamous Cell Carcinoma. DNA Cell Biol 2021;40:1503-12. [PMID: 34931868 DOI: 10.1089/dna.2021.0674] [Reference Citation Analysis]
59 Bellini MF, Silva AE, Varella-Garcia M. Genomic imbalances in esophageal squamous cell carcinoma identified by molecular cytogenetic techniques. Genet Mol Biol. 2010;33:205-213. [PMID: 21637470 DOI: 10.1590/s1415-47572010005000028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
60 Guo XZ, Zhang G, Wang JY, Liu WL, Wang F, Dong JQ, Xu LH, Cao JY, Song LB, Zeng MS. Prognostic relevance of Centromere protein H expression in esophageal carcinoma. BMC Cancer. 2008;8:233. [PMID: 18700042 DOI: 10.1186/1471-2407-8-233] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
61 Scherübl H, von Lampe B, Faiss S, Däubler P, Bohlmann P, Plath T, Foss HD, Scherer H, Strunz A, Hoffmeister B. Screening for oesophageal neoplasia in patients with head and neck cancer. Br J Cancer. 2002;86:239-243. [PMID: 11870513 DOI: 10.1038/sj.bjc.6600018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
62 Chang X, Yamashita K, Sidransky D, Kim MS. Promoter methylation of heat shock protein B2 in human esophageal squamous cell carcinoma. Int J Oncol 2011;38:1129-35. [PMID: 21258768 DOI: 10.3892/ijo.2011.918] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
63 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(9): 2222-2225 [DOI: 10.11569/wcjd.v12.i9.2222] [Reference Citation Analysis]
64 Lian X, Baranova A, Ngo J, Yu G, Cao H. UGT2B17 and miR-224 contribute to hormone dependency trends in adenocarcinoma and squamous cell carcinoma of esophagus. Biosci Rep 2019;39:BSR20190472. [PMID: 31164411 DOI: 10.1042/BSR20190472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Goessel G, Quante M, Hahn WC, Harada H, Heeg S, Suliman Y, Doebele M, von Werder A, Fulda C, Nakagawa H, Rustgi AK, Blum HE, Opitz OG. Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesis. Proc Natl Acad Sci U S A 2005;102:15599-604. [PMID: 16239349 DOI: 10.1073/pnas.0409730102] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
66 Feller L, Lemmer J. Cell transformation and the evolution of a field of precancerization as it relates to oral leukoplakia. Int J Dent 2011;2011:321750. [PMID: 22007217 DOI: 10.1155/2011/321750] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
67 Zhou CQ, Liu S, Xue LY, Wang YH, Zhu HX, Lu N, Xu NZ. Down-regulation of γ-synuclein in human esophageal squamous cell carcinoma. World J Gastroenterol 2003; 9(9): 1900-1903 [PMID: 12970872 DOI: 10.3748/wjg.v9.i9.1900] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
68 Ding ZL, Shi RH, Zhu H, Ling TS, Hao B. RNA interference-mediated down-regulation of Akt attenuates cell proliferation and migration in human esophageal squamous cell carcinoma cell line Eca109. Shijie Huaren Xiaohua Zazhi 2011; 19(5): 451-456 [DOI: 10.11569/wcjd.v19.i5.451] [Reference Citation Analysis]
69 Kaneko K, Katagiri A, Konishi K, Kurahashi T, Ito H, Kumekawa Y, Yamamoto T, Muramoto T, Kubota Y, Nozawa H, Makino R, Kushima M, Imawari M. Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus. Br J Cancer 2007;96:492-8. [PMID: 17285122 DOI: 10.1038/sj.bjc.6603582] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
70 Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J, Swisher SG, Wu TT, Ajani JA, Xu XC. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer. 2011;128:132-143. [PMID: 20309880 DOI: 10.1002/ijc.25330] [Cited by in Crossref: 113] [Cited by in F6Publishing: 115] [Article Influence: 9.4] [Reference Citation Analysis]
71 Wang HM, Zheng NG, Wu JL, Gong CC, Wang YL. Dual effects of 8-Br-cAMP on differentiation and apoptosis of human esophageal cancer cell line Eca-109. World J Gastroenterol 2005; 11(41): 6538-6542 [PMID: 16425431 DOI: 10.3748/wjg.v11.i41.6538] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
72 Wu MY, Zhuang CX, Yang HX, Liang YR. Expression of Egr-1, c-fos and cyclin D1 in esophageal cancer and its precursors: An immunohistochemical and in situ hybridization study. World J Gastroenterol 2004; 10(4): 476-480 [PMID: 14966901 DOI: 10.3748/wjg.v10.i4.476] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
73 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(11): 1777-1781 [DOI: 10.11569/wcjd.v11.i11.1777] [Cited by in F6Publishing: 3] [Reference Citation Analysis]